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Abstract There are currently no biomarkers to assess which
patients with chronic indeterminate Chagas disease will devel-
op heart disease and which will spend their entire life in this
state. We hypothetize that the parasite burden and
Trypanosoma cruzi genotypes are related to the presence of
heart disease in patients with Chagas disease. This study is
aimed to investigate the parasite burden and T. cruzi genotypes
in chagasic cardiopaths versus chagasic individuals without
cardiac involvement according to the New York Heart
Association. Patients with chronic Chagas disease, 50 with
and 50 without cardiopathy (controls), groups A and B, re-
spectively, were submitted to anamnesis, physical examina-
tion, and electrocardiogram. Echo-Doppler was performed
for group A; all important known causes of cardiopathy were
discarded. Xenodiagnosis, conventional PCR, and quantita-
tive PCR were performed on patients of both groups.
T. cruzi genotyping was done for 25 patients of group A and
20 of group B. The 50 cardiopaths had 80 electrocardiograph-
ic alterations, most of them in grade II of the New York Heart
Association classification; 49 were classified in grade I by
Echo-Doppler, and only one patient was in grade III. The
difference in average parasitemia in patients of groups A and
B was not significant. The most frequent T. cruzi DTU found
was TcV. The parasite burden and genotype of the groups with
and without cardiopathy were similar.
Figure 2 Chronic Chagas cardiopathy microaneurism of
left ventricle. Cineangiography
Keywords Chagasic cardiopaths . Trypanosoma cruzi
DTUs . Parasite burden . Genotypes
Introduction
Chagas disease (ChD) is a pathology that affects about 6–7
million people in the American continent (WHO 2015) where
it is autochthonous and has been introduced into Europe, Asia,
and Oceania through human migration (Basile et al. 2011;
Molina-Berríos et al. 2013). There are 80–100 million people
at risk of acquiring the disease (Salvatella 2012).
ChD is currently one of the most important neglected dis-
eases. It represents the fourth disease in importance in years
lost due to incapacity (Tarleton and Curran 2012; Apt et al.
2013). Two periods characterize the natural evolution of the
disease, acute and chronic; the latter with persistent infection
in the heart and adipose tissue (Wen et al. 2014) may be latent,
indeterminate, or determinate (Coura and Viñas 2010; Rassi
et al. 2010). Less than 5 % of the individuals in the acute
period develop symptomatology, especially in children. Fifty
to seventy percent of chronic chagasic cases have a latent or
indeterminate stage which lacks clinical symptoms and with
normal routine clinical laboratory tests; 10–30 % develop car-
diac pathology and 8–10 % digestive commitment. Without
doubt, chronic Chagas cardiopathy is the worst form of the
disease, due to its morbidity and mortality (Rassi et al. 2010).
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Young people with ChD and normal ECG have periods of
survival nine times greater than chagasic persons of the same
age with an abnormal electrocardiogram (Rassi et al. 2009).
Patients with cardiomyopathy due to Trypanosoma cruzi and
cardiac insufficiency have worse prognosis than those heart
myopathies with decompensated heart failure due to other
aetiologies (69.2 v/s 47.9 % mortality at 1 year, respectively)
(Silva et al. 2008). The outcome of Chagas cardiomyopathy is
worse than idiopathic cardiomyopathy (Barbosa et al. 2011).
Chagas cardiomyopathy presents a higher frequency of stroke
compared to a non-Chagas cohort (Da Matta et al. 2012). The
annual cost of Chagas cardiomyopathy, including both health
costs and disability-adjusted annual losses, exceeds that which
is originated by cervical uterine cancer and rotavirus, accord-
ing to simulated computer models (Lee et al. 2013). About
50–60 % of the people with the indeterminate form remain in
this asymptomatic state for life. For example, Berenice, the
first patient of Carlos Chagas (discoverer of the disease)
whose ChD diagnosis was performed at age of two, died at
82 years of age without presenting any symptomatology due
to ChD in her life. In Brazil and Chile, 1–2 % of the patients
with indeterminate chronic ChD develop cardiopathy each
year.
It is very important to know which infected subjects will
develop heart disease and who will not, to apply etiologic
therapy to the former and not to all the patients with indeter-
minate chronic ChD. To date, no biomarkers are available to
answer this question (Venegas et al. 2010; Requena-Méndez
et al. 2013; Urbina 2015). To determine whether the parasite
burden and T. cruzi genotypes are related to the presence of
heart disease in patients with ChD, we conducted this study
aimed to investigate the parasite burden and T. cruzi discrete
typing units (DTUs) TcI-TcVI in chagasic cardiopaths versus
chagasic individuals without cardiac involvement according




Adult patients with chronic ChD of the IVregion (Coquimbo),
Chile from the localities of Illapel and Salamanca (Choapa
province) and Combarbalá (Limarí province), hyperendemic
areas located between 29° 02´ and 32° 16´ South latitude,
were examined twice a year in outpatient clinics (rural pa-
tients) and hospitals (urban patients) by our investigation
group. They were submitted to anamnesis, physical examina-
tion, and ECG of twelve leads. The patients were divided into
two groups according to whether or not they presented ECG
alterations. Fifty individuals with chronic chagasic cardiopa-
thy were randomly selected (group A) and 50 without
cardiopathy (group B). Echo-Doppler was performed on the
patients of group A to eliminate other important known causes
of cardiopathy, hypertension, valve disease, atherosclerosis,
myocardiopathy, and congeni ta l malformat ions .
Xenodiagnosis (XD), conventional PCR (cPCR), and quanti-
tative PCR (qPCR) for T. cruzi were performed on patients of
both groups. Genotyping of T. cruzi was successful in 25
patients of group A and 20 of group B.
Ethics statement
The participation of the patients was under Informed Consent
approved by the Ethical Committee of the Faculty of
Medicine of the University of Chile (Protocol No. 048-11).
Informed consent from patients was given in written form.
Conventional serology
In the IIF test, epimastigote forms of T. cruzi, Tulahuén strain,
were used as antigens. They were cultured in Diamond medi-
um supplemented with 5 % fetal bovine serum maintained at
28 °C. In the exponential growth phase, parasites were col-
lected by centrifugation at 1300g for 10 min at 4 °C (Maya
et al. 2007). Titers equal or superior to 1/20 dilutions were
considered positive. In each determination, positive and neg-
ative controls from chagasic and non-chagasic individuals
were included. An ELISA test was applied using Chagatek
ELISA (BioMerieux, France). The optical density corre-
sponding to the cutoff value was determined by the average
of the negative control plus 0.100. The ELISA OD values for
the negative controls in the different assays fluctuated between
0.001 and 0.09. The plate was read in a spectrophotometer
PHOMO of Autobio, by indications of Micro-Elisa System.
Conventional xenodiagnosis
The colony of Triatoma infestans used in xenodiagnosis (XD)
has been maintained in our laboratory for 50 years fed on
chickens, which are normally refractory to T. cruzi
(Schenone 1999). XD was applied using two cylindrical
wooden boxes each containing seven uninfected third or
fourth instar nymphs of T. infestans starved for a period of
3–4 weeks. The insects of the cages were fed by patients
and then maintained at 27 °C and 70 % relative humidity
without further feeding. After 30, 60, and 90 days of incuba-
tion, the rectal contents of triatomines fed on each patient were
obtained by slight abdominal compression in a biologically
secure hood, for examination under an optical microscope
at ×40, 100 fields were observed to detect mobile
trypomastigotes or epimastigotes of T. cruzi. The criteria to
determine a negative XD was the absence of mobile forms of
T. cruzi in the three periods of microscopic observation (30,
60, and 90 days) (Saavedra et al. 2013).
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Electrocardiographic tracing
The patients were evaluated by a twelve-lead electrocardio-
gram. Each electrocardiographic trace included the following
parameters: P axis, P duration, P-R space, R-R space, R space,
QT value, QTc calculation, QRS axis, T axis, ventricular gra-
dients, RV1 intrensicoide deflexion, SV1, RVS, Sokolow in-
dex, and an electrocardiographic diagnosis. The final interpre-
tation of this test data was performed by a specialist cardiolo-
gist following the double blind protocol recommended by the
World Health Organization; the investigator analyzing the
ECG traces was unaware of the status of the patients
(Maguire et al. 1982).
Echo-Doppler
The Echo-Doppler was performed in Baquedano Square
Medical Image Centre of Santiago, Metropolitan Region,
Chile, with a latest generation Philips apparatus. The follow-
ing parameters were measured with bi-dimensional M mode:
systolic diameter of left ventricle, diastolic diameter of left
ventricle, septum of left ventricle, posterior wall of left ventri-
cle, left auricular size, hypertrophic sign of left ventricle, mass
of left ventricle, and ejection fraction of left ventricle. The
Doppler measurements allowed the determination of the status
of the different valves and the presence of reflux. The final
interpretation of this test was performed by a cardiologist spe-
cialist in echography.
DNA extraction
Five milliliters of venous blood of each patient was mixed
with the same volume of a 6 M guanidine hydrochloride
0.2 M EDTA pH 8.0 solution, incubated at 98 °C for 15 min
to nick DNA of T. cruzi minicircles and stored at 4 °C. DNA
extraction was performed in 200 μL of the samples mixture,
using the QIAamp® DNA Blood Mini Kit (Qiagen, Valencia,
CA) according to the manufacturer`s instructions. The puri-
fied DNAwas maintained at −20 °C until use.
Conventional PCR
Conventional PCR (cPCR) was performed in triplicate using
oligonucleotides 121 and 122, which anneal to the four con-
served regions present in T. cruzi minicircles (Degrave et al.
1988), to obtain 330 bp amplicons. Each sample was tested in
a final volume of 20 μL including 5 μL of extracted DNA.
The final concentrations of the reagents were as follows:
2.5 mMMgCl2, 0.2 mM of each dNTP, 0.5 μM of each prim-
er, and 1 unit GoTaq DNA polymerase (Promega Corp.,
USA). The amplification program was performed in a TC-
412 thermal cycler (Techne, UK) which included an initial
denaturation at 98 °C for 1 min and 64 °C for 2 min; 33 cycles
of 94 °C for 1 min, 64 °C for 1 min and 72 °C for 1 min, and a
final extension at 72 °C for 10 min. Each experiment included
two negative PCR controls: water instead of DNA and DNA
of non-chagasic patients. As positive control purified DNA of
T. cruzi Tulahuén strain was used. Amplification products
were analyzed by electrophoresis in a 2 % agarose gel and
visualized after staining with RedGel (Biotium Inc.). Five mi-
croliter Bench Top 100 bp DNA ladder (Promega Corp.,USA)
was incorporated. A positive result for cPCRwas the presence
of a 330 bp band specific for T. cruzi minicircles.
Quantitative PCR for Trypanosoma cruzi (qPCR)
The TaqMan® detection system was applied in a Stratagene
MX3000PTM thermocycler (Agilent Technologies) under con-
ditions suggested by the manufacturer and using primers of
DNA satellite Cruzi 1, Cruzi 2, and Cruzi 3 (Schijman et al.
2011). The reaction mixture consisted of 2 μl of the sample to
be investigated, 10 μl Brilliant Multiplex QPCR Master mix
(Stratagene), 0.5 μl of a 1:500 dilution of a reference dye
(ROX), 0.5 μl each of Cruzi 1, and Cruzi 2, 0.2 μl Cruzi 3,
0.2 μl BSA (100x) and 6.1 μl Molecular Biology GradeWater
(Mo Bio Laboratories Inc.) in a final volume of 20 μl. To
obtain a standard curve to perform the quantification, we used
a stock of epimastigote forms of T. cruzi, Tulahuen strain. The
total DNA quantification was carried out using AccueBlue™
High Sensitivity dsDNA Quantitation kit (Biotum Inc.) and
the qPCR instrument Mx3000P ™ (Stratagene, Agilent
Technologies Inc.) as detector devices according to Bravo
et al. (2012). A T. cruzi DNA concentration equivalent to
1×106 epimastigotes/ml was adjusted, considering that 1 par-
asite cell contains 200 fg of DNA(Duffy et al. 2009). The
DNA was diluted 1:10. The standard curve of T. cruzi was
maintained at −20 °C until use.
The controls used for qPCR-T. cruzi were as follows: neg-
ative control, DNA of a non-chagasic patient confirmed by
serology (IIF and ELISA), evaluated previously with qPCR
equipment and positive controls, DNA of an individual with
ChD with confirmed parasitemia by PCR and evaluated pre-
viously in qPCR equipment. Control mixture: 20 μl of mix-
ture reaction for T. cruzi (without the sample under study).
Water control: 2 μl of water free of nucleases (Mo Bio
Laboratories Inc.) (replacing the study sample). The control
mixture and water control are useful to evaluate contamination
in the preparation of the mixture reaction or unspecific qPCR
reactions. Each point of the standard curve was performed in
triplicate. The samples and controls were included in dupli-
cate. As an internal control of extraction and inhibition of
qPCR, we used chromosome 12 (X12) (Bravo et al. 2012).
X12 primers were designed by N. Jullien using the AmplifX
v.1.5.4 software, and compared with Nucleotide BLAST
(National Library of Medicine) to discount any other unspe-
cific amplification (N. Nazal, personal communication). The
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N1X12 forward (5′-GCTGGCTAGACTGTCAT-3′) and
N2X12 reverse (5′-CTTTGCCGTTGAAGCTTG-3′) and
N3X12 probe (N3X12 5′-/56-FAM/TGGGACTTC/ZEN/
AGAGTAGGCAGATCG/3IABkFQ/-3′) primers were used.
The standard curve for X12 was prepared with a pool of hu-
man genomic DNA of five non-chagasic individuals diluted 1/
5 in elution buffer. The reaction mixture was composed of
10 μl Brilliant Multiplex QPCR Master Mix, 0.5 μl of a
1:500 solution of Reference Dye (ROX), 2 μl each N1/N2,
0.8 μl N3, 0.2 μl BSA (100x), 2.5 μl Molecular Biology
Grade water (Mo Bio Laboratories, Inc.), and 2 μl of DNA
isolate in a final reaction volume of 20 μl. The thermals pro-
files of qPCR-T. cruzi and qPCR-X12 included 10 min of pre-
incubation at 95 °C and 40 amplification cycles (95 °C for
15 s, 60 °C for 1 min). The measurement of emitted fluores-
cence was performed at 60 °C at the end of each cycle. The
MxPro v4.1 (Agilent Technologies) software delivered auto-
matically the parasites/ml data.
Hybridization assays
T. cruzi genotyping was performed twice by DNA blot anal-
ysis of DNA minicircle amplicons in 75 patients. In 21 of
them, the concentration of PCR products was below the min-
imum required for hybridization tests. The primers for probe
generation were CV1 (5′-GATTGGGGTTGGAGTACTAT-
3′) and CV2 (5′-TTGAACGGCCCTCCGAAAAC-3′), which
produced a 270-bp fragment. These fragments were further
digested with restriction endonucleases Sau96I and ScaI
(Fermentas, Ontario, Canada) to obtain a 250-bp band and
remove all sequences from the minicircle constant region.
Finally, the probes sp104c11 (TcI), CBBc13 (TcII), NRc13
(TcV), and v195cl1 (TcVI) were labeled using the random
primer method with [α-32P] dATP. The membranes were
pre-hybridized in a solution of 6×SSC and 1 mM EDTA pH
7.4 with salmon sperm DNA at 55 °C. The membranes were
hybridized overnight with the labeled probe at 55 °C in the
same solution and then washed in high-stringency conditions
(0.1×SSC and 0.1×SDS at 68 °C). The membranes were ex-
posed for 1–4 h in a Molecular Imager (FX Bio Rad
Laboratories, Hercules, CA). This method has been validated
by hybridization with the probes constructed by PCR ampli-
fication of T. cruzi DNA from different kDNA DTU typing
(Veas et al. 1991; Brenière et al. 1995, 1998; Solari et al. 2001;
Rodríguez et al. 2009; Arenas et al. 2012). The hybridization
profiles were analyzed to compare the intensity of the
ethidium bromide-stained bands in each membrane with the
presence of the radioactive bands obtained with each probe.
The specificity of the probes was tested in hybridization con-
trols against DNA of the probes themselves. The profiles of
radioactive hybridization signals with multiple probes are in-
dicative of mixed infections with several genotypes of
T. cruzi.
Statistical analysis
The data were analyzed using the SPSS program version 19.0.
The description of the data was performed by tables, arithmet-
ic mean, mode, standard deviation, and amplitude of the var-
iable. Chi square was applied for group comparison of quali-
tative variables. In the case of quantitative variables, Levene
tests were applied to evaluate the homoscedasticity and
Student’s t test to evaluate the average burden. A significance
level of 0.05 was used.
Results
Age, gender, and geographical origin of groups A and B
Ages of the individuals of group A ranged from 30 to 81 years,
average 58.3. Sixty percent of the patients were women. Most
patients were from Combarbalá (58 %), and 70 % lived in
rural zones. In group B, the average age was 49.6 years, rang-
ing from 20 to 76 years old. Eighty percent of the patients
were women. Most patients were from Illapel (42 %), and
66 % lived in rural zones. The patients of groups A and B
were examined in the outpatient clinics and hospitals where
they live between 2011 and 2013. The average age of group A
is significantly greater that of group B (t=3.39; p=0.001)
(Tables 1 and 2).
Serological results
The titers of the IIF IgG were between 1/40 and 1/1280, and
the OD of the ELISAwas 0.17 to 2.575. The OD values from
the ELISA and titers from the IIF tests demonstrated broad
agreement for patients exhibiting both strong and weak sero-
logical responses, in agreement with previous studies
(Umezawa et al. 1996; Luquetti et al. 2009) (Tables 1 and 2).
Parasite burden and genotypes
The averages obtained in the standard curves of qPCR for
T. cruzi for the parameters were as follows: correlation coef-
ficient (R2) 1.00, slope (Y) 3.46, and efficiency (Eff) 94.45.
The Ct averages for each point of the standard curve were as
follows: 105 parasites/ml Ct: 16.59; 104 parasites/ml Ct:
19.97; 103 parasites/ml Ct: 23.47; 102 parasites/ml Ct: 27.11;
101 parasites/ml Ct: 30.65; 1 parasites/ml Ct: 33.47; 10−1
parasites/ml Ct: 36.71. In the cases of group A, the parasite
burden fluctuated between 32.99 and 39.99, corresponding to
2.38 and 0.009 parasites/ml, respectively. The average Ct in
the 50 patients of this group was 36.88. In the cases of Group
B, Ct fluctuated between 33.88 and 39.92, corresponding to
1.27 and 0.01 parasites/ml, respectively. The average Ct in the
50 patients of this group was 37.23. In the standard curve, the
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last point corresponds to 0.1 parasites/ml. Automatic interpo-
lation occurred where the T. cruzi parasitemia estimated by
qPCR was less than 0.1 parasites/ml using the MxPro v4.1
(Agilent Technologies) software package. Average levels of
parasites did not differ significantly between patients of
groups A and B.
In group A, the parasitological evaluation demonstrated
that cPCR and qPCR were positive in 40 (80 %) and 43
(86 %) of the cases, respectively, nevertheless XD was posi-
tive only in 10 cases (20 %). In group B, without cardiopathy,
cPCR and qPCR were positive in 35 (70 %) and 35 (70 %) of
the cases, respectively, nevertheless XD was positive only in
10 cases (20 %).
The number of patients with positive qualitative and quan-
titative amplification of parasite DNA (cPCR and qPCR) was
greater in group A compared to group B, 40 v/s 35 and 45 v/s
35 cases, respectively, but without statistical significance. Of
the 100 individuals included in this study, 75 were cPCR
positive. Of these, 45 were hybridized for genotyping. In the
other 30 samples, T. cruzi DNAwas insufficient for (21 sam-
ples) or were not recognized by the probes used (9 samples).
According to representative results (Fig. 1), the most frequent
T. cruzi DTU was TcV, but also TcI, TcII, TcVI, and mixtures
up to three were circulating in peripheral blood (Table 3).
Electrocardiographic and Echo-Doppler alterations
of group A
The 50 cardiopaths of group A had 80 electrocardiographic
alterations (Table 1). According to the NYHA classification,
group Awas divided into two sub-groups. In sub-group I, the
17 patients showed electrocardiographic alterations of grade I
NYHA classification (1994; Andrade et al. 2011). There were
15 cases, 9 men and 6 women aged 38 to 81 years, who
showed sinus bradycardia from 41 to 58 pm in the ECG trac-
ing. In two others, one man of 46 and a woman of age 56 years
right bundle branch block was incompletely blocked. In sub-
group II, 14 women and 6 men had more than one electrocar-
diographic alterations. In eight cases, six women and two men
aged 48 to 79 years had sinus bradycardia ranged. Three of
these women had first-degree A-V block and prolonged QTc
interval associated with bradycardia, in two cases and left
ventricle hypertrophy in the others. One women had left an-
terior hemiblock, another had bradycardia in association with
prolonged QTc interval, and the last woman showed ischemia
in association with bradycardia. One man had left ventricle
hypertrophy associated with bradycardia and the others
prolonged QTc interval. Ten cases, 7 women and 3 men aged
49 to 77 years showed left anterior hemiblock, alone in 3
cases, one in association with left ventricle hypertrophy and
in another two with prolonged QTc time, ventricular extrasys-
tole and incomplete right bundle branch block, in association
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ischemia and auricular extrasystole, one with complete right
bundle branch block and prolonged QTc interval and the last
with sinus bradycardia (already mentioned). Prolonged QTc
time appeared in 17 cases (12 women aged 31 to 79 years and
4 men aged 36 to 49 years). This was an isolated finding in
three cases; in the other 14, it was associated. First A-V block
was present in four patients, isolated in one, and the other three
were associated (Table 1). Most of the patients of group A
were in grade I or II of the NYHA classification. The Echo-
Doppler was normal in 49 cases. One patient (number 21)
with sinus bradycardia had a low ejection fraction (56 %)
(Table 1). Gender and cardiopathy were not associated.
Comorbility
In relation to comorbidity, 34 (68 %) patients of group A and
25 (50 %) of group B did have an associated pathology. This
difference is not statistically significant (z=1.43, p=0.0764).
The most frequent concomitant pathology in groups A and B
was hypertension (58.8 and 48 %, respectively), followed by
hypercholesterolemia in group A (29.4 %) and cholecystecto-
my in group B (36 %) (Tables 1 and 2).
Discussion
The majority of the patients of group A (70 %) and group B
(66.0 %) live in rural zones, where they have more contact
with infected vectors and whose houses are appropriate for the
development of the vectors (Briceño-León 1990; Schofield
1994; Gomes et al. 2013). This area is currently free of
T. infestans, the most important domiciliary vector of
Chagas disease (OPS/OMS 2000). Comparing the age groups
(Tables 1 and 2) shows that there are more older people in
group A (above 70 years) and more younger people in group
B (under 30 years), and that the average age of group A,
57.8 years, is significantly greater than that of group B,
49.6 years. These results are consistent, since Chagas cardi-
opathy requires a prolonged period to develop (Elizari 1999;
Rassi et al. 2009; Morillo 2013). In the present study, the
cardiopathy increased with age. Females predominated in
both groups (60 and 80 % group A and B, respectively) due
to the greater attendance of women in clinical controls for
Chagas disease, while their husbands were working and the
greater willingness of women from endemic zones to transfer
to the Metropolitan Region to perform cardiac Echo-Doppler.
No association between sex and cardiopathy was observed;
similar results were obtained by other investigators (Pereira
et al. 1990; Silva et al. 2007), but are discordant with
Basquiera et al. (2003), who reported more males with
Chagas cardiomyopathy.
The results of the parasitological study of group A showed
that the percentages of detection of T. cruzi by XD, cPCR, and
qPCR were 20, 80, and 86 %, respectively. In the group B, the
percentages were 20, 70, and 70 %, respectively. XD was
positive in 20 % of groups A and B, concordant with literature
where the sensitivity in chronic Chagas patients fluctuated be-
tween 5.3 and 50 % (Basso and Moretti 1984; Pereira et al.
1992; Siqueira-Batista et al. 1994). Three cases were XD (+)
and PCR (−) (2 in group A and 1 in group B). Except for these,
there was no discordance between XD and qPCR.
The results of sensitivity obtained by cPCR are also con-
cordant with other studies on this period of the disease, with
percentages between 43 and 75.2 % (Hidron et al. 2010;
Gilber et al. 2013). In this study, the concordance between
cPCR and qPCR in groups A and B was 78 and 84 %, respec-
tively. The seven cases of group A and 4 of group B, with
positive qPCR and negative cPCR, presented loads very close
to the lower limit of the dynamic range established (between
0.009–0.04 parasites/ml). The quantification limit of qPCR






















































Cases 1-50: cardiopaths; cases 51-100: no cardiopaths 
Fig. 1 Trypanosoma cruzi cPCR
amplicons stained with ethidium
bromide (A). Hybridization
profiles obtained with genotypes
specific probes corresponding to
TcI (B), TcII (C), TcV (D), and
TcVI (E). The 330 base pair (bp)
product represents a positive as-
say. Cases 1–50: cardiopaths;
cases 51–100: no cardiopaths
Table 3 Genotypes of Trypanosoma cruzi in 25 cardiopaths group A
and 20 non-cardiopaths group B of Chile
Group A Group B
Infection Single 18 (72 %)a 15 (75 %)c
Mixed 7 (28 %)b 5 (15 %)d
Total 25 20
The most frequent DTUwas the following: a TcV (15 cases), b TcV-TcVI-
TcII (2 cases), c TcV (10 cases), and d TcV-TcVI (2 cases)
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of group A and four cases of group B had positive cPCR and
negative qPCR. The sensitivity of kDNA cPCR in our labo-
ratory with 5 ml of peripheral blood, if there is at least one
intact parasite, the detection limit is 0.2 genomic equivalents
(Schijman et al. 2003). This discordance was probably due to
the use of different parasite targets, kDNA for cPCR and nu-
clear satellite DNA for qPCR (Moreira et al. 2013). No sig-
nificant difference was found between average parasite burden
in patients of group A and B, nevertheless in group B, there
was a higher proportion of cases without parasites detectable
by qPCR (15 against 7), and in group A, two cases were found
with more than two parasites/ml of blood. This result differs
from (Mosca et al. 1985) who demonstrated higher
parasitemia by XD in cardiopaths than chronic chagasic pa-
tients without cardiopathy. It is also important to consider that
parasitemia does not always represent the parasite burden;
tissue parasite burden represents more exactly T. cruzi burden
of chagasic patients (Vago et al. 2000; Valadares et al. 2008).
Another study concluded that parasitemia does not correlate
with the number of alterations detected in the electrocardio-
graphic tracing (Tarleton and Curran 2012).
T. cruzi DTUs circulating in cardiopaths and non-
cardiopaths appear to be the same. TcVwas the most abundant
and TcI the least frequent DTU detected in these patients, even
though other not identified DTUs are also circulating in some
patients. The presence of mixed DTUs (11/21) and undeter-
mined DTUs (9/21) were also reported in a previous survey
(Muñoz et al. 2013)
Our results agree with an experimental survey in
mice inoculated with three main T. cruzi genotypes, in
which all resulted with cardiomyopathy (De Diego et al.
1998) and TcV, the most frequent genotype in Argentina
(Burgos et al. 2007; Cura et al. 2012). They differ from
the genotypes more frequently observed in patients with
cardiomyopathy, TcI in Colombia and Venezuela,, TcII
in Brazil (Ramírez et al. 2010; Segovia et al. 2013)
Therefore, ECG alterations are not related to the number
or genotype of parasites. In addition, mild cardiopathies
of Colombia and Argentina had 20 times higher parasite
loads than patients from Brazil with severe cardiopathy
(Moreira et al. 2013).
The diagnosis of Chagas cardiomyopathy was made
based on clinical examination, results of the ECG and
cardiac Echo-Doppler, which allowed ruling out the most
important cardiomyopathies of other etiologies. In rela-
tion to comorbidity, hypertension was the most frequent
pathology observed in both groups (Tables 1 and 2). In
patients of group A who had hypertension and/or hyper-
cholesterolemia, the cardiopathy was due to ChD and not
to hypertension, as the ECG showed no left ventricular
hypertrophy and the cardiac Echo-Doppler was normal.
Group A had a greater co-morbidity (68 %) than group B
(54 %); however, the difference is not statistically
significant. Atherosclerosis was discounted as a con-
founding variable of the clinical data of heart pathology
in the cohort, and no patients had a history of angina.
The ECG analysis of the cohort showed no signs of
ischemia and the cardiac Echo-Doppler was normal. In
groups A and B, 6 and 9 women, respectively, had been
cholecystectomized; this figure is not exceptional, be-
cause in Chile, 55 % of women over age 50 years have
a gallbladder pathology (Braghetto et al. 2011). Two men
of group A were also cholecystectomized, confirming
that this pathology is also common in men. Ten patients
had gastrointestinal involvement, three had esophagus
achalasia, 1 of group A and 2 of group B, one patient
of group B had megacolon, another a colon cancer, one
had chronic gastritis, and the last a gastric ulcer. Three
patients of group A had chronic gastritis. The electrocar-
diographic tracing was the basic clue for diagnosis of
Chagas cardiomyopathy; 80 abnormalities were observed
in the 50 cardiopaths. Sinus bradycardia was the most
frequent alteration (23 cases, 28.5 %); in 15 patients, it
was the only alteration of the serial ECG performed (at
least three); none of these cases corresponded to athletes
or people who do heavy work or received bradycardic
vagotonic drugs that could cause this pathology. The
eight associated cases correspond to the following:
prolonged QTc interval (2), first-degree A-V block and
prolonged QTc interval (2), one with LAHB, another
with A-V first-degree block plus prolonged QTc interval
and left ventricular hypertrophy; one case presented sinus
bradycardia anterior ischemia and the last ventricular hy-
pertrophy. The prolonged QTc interval is one of the first
elements altered in the ECG of chagasic cardiopaths ac-
cording our experience; this was present in 17 cases
(21.25 %); in three of these it was the only alteration
present. In the remaining 14, it was associated with sinus
bradycardia (2), ventricular extrasystoles (2), sinus bra-
dycardia plus first-degree A-V block (2), left anterior
hemiblock (2), and complete right bundle branch block
(2); the remaining four corresponded to left anterior
hemiblock plus complete right bundle branch block,
two to repolarization abnormalities and the last to systol-
ic bradycardia plus left ventricle hypertrophy and first-
degree A-V block. According to the electrocardiographic
alterations, most of the 50 chagasic cardiopaths corre-
spond to grade I, 17 cases (34 %) and grade II, 33 cases
(66 %) of the NYHA classification; similar percentages
were observed in Brazil (Rassi et al. 2010]. The most
frequent electrocardiographic alterations of the group of
cardiopaths were sinus bradycardia and prolonged QTc
interval. The majority correspond to grades I and II of
the NYHA classification. The parasite burden and geno-
types of the group with Chagas heart disease and patients
with indeterminate Chagas disease were similar.
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